Hungary Becomes First EU Country To Use Russian Vaccine

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare

The 4th Annual "Internet + Pharma" Service Innovation Conference,...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Hungary on Friday began innoculating its population with the Russian-made Sputnik V coronavirus vaccine. The vaccinations began in four hospitals in the country’s capital Budapest, according to Chief Medical Officer, Cecilia Muller.

Speaking during a news conference, Muller said around 2,800 doses of the Russian vaccine were expected to be administered on Friday.

Hungary also expects to receive 500,000 doses of the Chinese Sinopharm COVID-19 vaccine next week, along with 200,000 doses of the Russian Sputnik V vaccine to arrive later this month.

The country has purchased enough Sputnik V doses to treat 1 million people and enough Sinopharm doses to treat 2.5 million, officials said.

The country’s government has been critical of the European Union’s sluggish vaccine rollout, and in recent months has sought vaccines from countries outside the bloc’s common procurement program.

Hungary’s Prime Minister Viktor Orban has rejected arguments that only vaccines approved by the European Medicines Agency, the EU’s medicines regulator, should be approved for use in Hungary.

He has also claimed the increasing proportion of Hungarians receiving COVID-19 vaccinations should be enough to prevent the need for new pandemic restrictions in Hungary, despite recent increases in infections and deaths.

A nighttime curfew of 8 p.m. to 5 a.m., limitation of restaurants to take-out and delivery service and mandatory shop closures at 7 p.m. have been in place in the country since November 11 and will remain in force until at least March 1.

As of Friday, 13,543 people had died in Hungary of coronavirus-related causes and 310,448 had received at least a first dose of a vaccine.

Latest stories

Related stories

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare

The 4th Annual "Internet + Pharma" Service Innovation Conference,...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back